Pr SIMBRINZA® (brinzolamide / brimonidine tartrate ophthalmic suspension) 1% / 0.2% w/v
Elevated Intraocular Pressure Therapy (Topical Carbonic Anhydrase Inhibitor and Topical Alpha-2 Agonist Agent)
Treatment of Glaucoma and Ocular Hypertension.
For qualified medical professional use only. Refer to User Manual for Canadian approved indication for use, cautions and precautions.
Innova is committed to keeping our site accessible to everyone. We welcome feedback on ways to improve the site’s accessibility so it is easy for everyone to navigate.
. 
Search